These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 34844510)

  • 1. Elucidation of the interaction mechanism of olmutinib with human α-1 acid glycoprotein: insights from spectroscopic and molecular modeling studies.
    Kou SB; Li L; Zhang RJ; Shi JH; Jiang SL
    J Biomol Struct Dyn; 2023 Feb; 41(2):525-537. PubMed ID: 34844510
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Insight into intermolecular binding mechanism of apatinib mesylate and human alpha-1-acid glycoprotein: combined multi-spectroscopic approaches with
    Jiang SL; Li L; Kou SB; Hu L; Shi JH
    J Biomol Struct Dyn; 2024; 42(2):779-790. PubMed ID: 37000929
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Insight into the binding behavior of ceritinib on human α-1 acid glycoprotein: Multi-spectroscopic and molecular modeling approaches.
    Wang BL; Kou SB; Lin ZY; Shi JH
    Spectrochim Acta A Mol Biomol Spectrosc; 2020 May; 232():118160. PubMed ID: 32113179
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Insights on the interaction mechanism of brigatinib to human α-1-acid glycoprotein: Experimental and computational approaches.
    Wang BL; Kou SB; Lin ZY; Shi JH; Liu YX
    Int J Biol Macromol; 2020 Aug; 157():340-349. PubMed ID: 32335105
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Spectroscopic, molecular docking and dynamic simulation studies of binding between the new anticancer agent olmutinib and human serum albumin.
    Alanazi AM; Bakheit AH; Attwa MW; Abdelhameed AS
    J Biomol Struct Dyn; 2022; 40(24):14236-14246. PubMed ID: 34766879
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comprehending the intermolecular interaction of dacomitinib with bovine serum albumin: experimental and theoretical approaches.
    Hu ZY; Wang WJ; Hu L; Shi JH; Jiang SL
    J Biomol Struct Dyn; 2024 Apr; 42(7):3579-3592. PubMed ID: 37288787
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comprehending binding features between ibrutinib and Human Alpha-1 acid glycoprotein: Combined experimental approaches and theoretical simulations.
    Jiang SL; Li L; Hu L; Kou SB; Shi JH
    Spectrochim Acta A Mol Biomol Spectrosc; 2023 Jan; 285():121834. PubMed ID: 36116409
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Investigation on the binding behavior of human α1-acid glycoprotein with Janus Kinase inhibitor baricitinib: Multi-spectroscopic and molecular simulation methodologies.
    Jiang SL; Hu ZY; Wang WJ; Hu L; Li L; Kou SB; Shi JH
    Int J Biol Macromol; 2023 Jul; 244():125096. PubMed ID: 37285878
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro investigation of the binding characteristics of dacomitinib to human α 1-acid glycoprotein: Multispectral and computational modeling.
    Hu ZY; Sui HY; Zhong QF; Hu L; Shi JH; Jiang SL; Han L
    Spectrochim Acta A Mol Biomol Spectrosc; 2024 Jun; 314():124197. PubMed ID: 38554689
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exploring the binding characteristics between lorlatinib and human alpha-1-acid glycoprotein: Multispectral and molecular modeling techniques.
    Sui HY; Chen D; Huang JP; Hu ZY; Hu L; Shi JH; Jiang SL
    Spectrochim Acta A Mol Biomol Spectrosc; 2025 Feb; 326():125197. PubMed ID: 39368180
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Probing the interaction of fisetin with human serum transferrin via spectroscopic and molecular docking approaches.
    Sandu N; Popescu AI; Chilom CG
    J Biomol Struct Dyn; 2022; 40(20):9613-9619. PubMed ID: 34098861
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of the binding between anti-tumor drug 5-fluorouracil and human alpha-2-macroglobulin: spectroscopic and molecular docking analyses.
    Zia MK; Siddiqui T; Ahsan H; Khan FH
    J Biomol Struct Dyn; 2022 Oct; 40(17):7949-7959. PubMed ID: 33798029
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exploring the combination characteristics of lumefantrine, an antimalarial drug and human serum albumin through spectroscopic and molecular docking studies.
    Musa KA; Ridzwan NFW; Mohamad SB; Tayyab S
    J Biomol Struct Dyn; 2021 Feb; 39(2):691-702. PubMed ID: 31913089
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multispectral and molecular simulation of the interaction of human α1-acid glycoprotein with palbociclib.
    Jiang SL; Wu YT; Chen WC; Huang JP; Chen D; Li L; Han L; Shi JH
    Biochim Biophys Acta Gen Subj; 2024 Nov; 1868(11):130712. PubMed ID: 39313164
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interaction of mancozeb with human hemoglobin: Spectroscopic, molecular docking and molecular dynamic simulation studies.
    Quds R; Amiruddin Hashmi M; Iqbal Z; Mahmood R
    Spectrochim Acta A Mol Biomol Spectrosc; 2022 Nov; 280():121503. PubMed ID: 35717929
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biomolecular interactions and binding dynamics of tyrosine kinase inhibitor erdafitinib, with human serum albumin.
    Amir M; Qureshi MA; Javed S
    J Biomol Struct Dyn; 2021 Jul; 39(11):3934-3947. PubMed ID: 32448054
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interaction of new kinase inhibitors cabozantinib and tofacitinib with human serum alpha-1 acid glycoprotein. A comprehensive spectroscopic and molecular Docking approach.
    Ajmal MR; Abdelhameed AS; Alam P; Khan RH
    Spectrochim Acta A Mol Biomol Spectrosc; 2016 Apr; 159():199-208. PubMed ID: 26851488
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biomolecular interaction mechanism of an anticancer drug, pazopanib with human serum albumin: a multi-spectroscopic and computational approach.
    Kandandapani S; Kabir MZ; Ridzwan NFW; Mohamad SB; Tayyab S
    J Biomol Struct Dyn; 2022 Nov; 40(18):8312-8323. PubMed ID: 33870854
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Spectroscopic methodologies and computational simulation studies on the characterization of the interaction between human serum albumin and astragalin.
    Lyu S; Wang W
    J Biomol Struct Dyn; 2021 May; 39(8):2959-2970. PubMed ID: 32306829
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structural dynamics studies on the binding of aflatoxin B
    Aamir Qureshi M; Javed S
    J Biomol Struct Dyn; 2020 Jul; 38(11):3144-3155. PubMed ID: 31378144
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.